Fusion Pharmaceuticals (FUSN, $21.42) was one of top quarterly gainers, jumping +11 to $21.42 per share. A.I.dvisor analyzed 916 stocks in the Biotechnology Industry over the last three months, and discovered that of them (5) charted an Uptrend while of them (4) trended down. A.I.dvisor found 195 similar cases when FUSN's price jumped over within three months. In out of those 195 cases, FUSN's price went up during the following month. Based on these historical data, A.I. thinks the odds of an Uptrend continuation for FUSN are